19. ライソゾーム病 Lysosomal storage disease Clinical trials / Disease details

臨床試験数 : 899 / 薬物数 : 684 - (DrugBank : 99) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 182

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02583672 (ClinicalTrials.gov)	September 2015	21/8/2015	Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)	Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1): Potential Use of Antioxid ...	Gaucher Disease Type 1	Drug: N-acetylcysteine	University of Minnesota	Rare Diseases Clinical Research Network;National Center for Advancing Translational Sciences (NCATS) ...	Recruiting	18 Years	N/A	All	50	Phase 2	United States
2	NCT01427517 (ClinicalTrials.gov)	July 2011	30/8/2011	Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease	Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease	Parkinson's Disease;Gaucher's Disease	Drug: N-acetylcysteine	University of Minnesota	Rare Diseases Clinical Research Network;National Center for Advancing Translational Science (NCATS); ...	Completed	18 Years	N/A	All	9	Phase 1	United States
3	NCT00028262 (ClinicalTrials.gov)	February 2001	17/12/2001	Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis	A Combination Therapy With Cystagon and N-Acetylcysteine for INCL Patients	Infantile Neronal Ceroid Lipofuscinosis	Drug: Cystagon	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	NULL	Completed	6 Months	3 Years	All	10	Phase 4	United States

First Previous1Next Last